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Abstract Metabolism of lanosterol (LAN), 24-methylene-
24,25-dihydrolanosterol (24-methyleneDHL), dihydrolanosterol
(DHL) and obtusifoliol (OBT) by purified human, plant
(Sorghum bicolor) and fungal (Candida albicans) sterol 14K-
demethylase (CYP51; P45014DM) reconstituted with NADPH
cytochrome P450 reductases was studied in order to elucidate the
substrate specificity and sterol stereo- and regio-structural
requirements for optimal CYP51 activity. Both human and C.
albicans CYP51 could catalyse 14K-demethylation of each
substrate with varying levels of activity, but having slightly
higher activity for their respective endogenous substrates in vivo,
dihydrolanosterol for human CYP51 (Vmax = 0.5 nmol/min/nmol
CYP51) and 24-methylene-24,25-dihydrolanosterol for C. albi-
cans CYP51 (Vmax = 0.3 nmol/min/nmol CYP51). In contrast, S.
bicolor CYP51 showed strict substrate specificity and selectivity
towards its own endogenous substrate, obtusifoliol (Vmax = 5.5
nmol/min/nmol CYP51) and was inactive towards 14K-demethyl-
ation of lanosterol, 24-methylene-24,25-dihydrolanosterol and
dihydrolanosterol. These findings confirm that the presence of
the 4L-methyl group in the sterol molecule renders the plant
CYP51 incapable of 14K-demethylation thus revealing the strict
active site conservation of plant CYP51 during evolution.
z 1998 Federation of European Biochemical Societies.
1. Introduction
Sterol 14K-demethylase (CYP51; P45014DM) [1,2] is a species
of cytochrome P450 which catalyses the oxidative removal of
the 14K-methyl group (C32) of lanosterol and 24-methylene-
24,25-dihydrolanosterol in yeasts and fungi, obtusifoliol in
plants and 24,25-dihydrolanosterol in mammals (Fig. 1).
This step is considered to be one of the key enzymes of sterol
biosynthesis of these organisms and is the target enzyme for
the azole antifungals, which are thought to selectively inhibit
the yeast and fungal forms over their plant and mammalian
counterparts [3].
Previously, the necessary structure of substrate for substrate
recognition and catalytic activity of puri¢ed Saccharomyces
cerevisiae CYP51 has been elucidated [4^6]. It was revealed
that the sterol ring v8 double bond and the 3-hydroxyl group
were essential for recognition by this CYP51 form. Experi-
ments with partially puri¢ed rat CYP51 also showed di¡er-
ences in recognition and a⁄nity for sterol derivatives. Reduc-
ing the length of the sterol side chain interfered with substrate
binding to rat CYP51, without an e¡ect on Vmax, but the yeast
enzyme exhibited reduced catalytic turnover [7]. This suggests
fundamental di¡erences in substrate recognition by di¡erent
CYP51s. Furthermore, studies using corn microsomes have
indicated the C4-demethylated substrate, obtusifoliol was me-
tabolised, but not C4-demethylated sterols [8]. For plants,
obtusifoliol was thought to be the endogenous substrate in
contrast to 24-methylenedihydrolanosterol for fungi and dihy-
drolanosterol in mammals, but this had not been subject to
rigorous analysis using puri¢ed enzyme in the case of the
plant and fungal (as opposed to yeast) enzyme. In this paper
the abilities of the puri¢ed CYP51 orthologues from the plant,
animal and fungal kingdoms, following heterologous expres-
sion, were evaluated for their a⁄nity and C14-demethylation
using the three endogenous substrates; obtusifoliol for Sor-
ghum bicolor CYP51, 24-methylene-24,25-dihydrolanosterol
for Candida albicans CYP51 and dihydrolanosterol for human
CYP51 (Fig. 1). Additionally, lanosterol, the substrate for
yeast CYP51, was assayed as a potential substrate for all three
forms.
2. Materials and methods
Human and C. albicans CYP51 were expressed in S. cerevisiae and
puri¢ed as previously described [9]. S. bicolor CYP51 was expressed in
E. coli and puri¢ed according to the method of Bak et al. [10]. Mam-
malian, fungal and plant NADPH cytochrome P450 reductases were
puri¢ed according to the method of Yasucochi and Masters [11].
Lanosterol was purchased from Sigma, Poole, UK. Dihydrolanosterol
and 24-methylene-24,25-dihydrolanosterol were gifts from Zeneca
Agrochemicals, Berkshire, UK and obtusifoliol was kindly provided
by Rachael Kahn, Plant Biochemistry Laboratory, The Royal Veteri-
nary and Agricultural University, Copenhagen, Denmark. All the
sterols used were of the highest purity (not less than 99%) as judged
by high performance liquid chromatography (HPLC) and gas chro-
matography/mass spectroscopy (GC/MS). All other chemicals used
were purchased from Sigma, Poole, UK. The 14K-demethylase activity
of the plant, C. albicans and human enzymes consisting of CYP51 and
its respective reductase was assayed according to previous methods
[12,13]. Each sterol was dispersed in dilaurylphosphatidylcholine
(DLPC) and added to the reaction mixture at varying concentrations.
The reconstituted system contained 0.1 nmol of each puri¢ed CYP51
and 1.0 unit of its respective NADPH cytochrome P450 reductase.
The activity was assayed by GC/MS determination of the deform-
ylated products. Brie£y, the sterols were extracted into heptane, dried
down and trimethylsilylated for 1 h at 60‡C with BSTFA (50 Wl) in 50
Wl toluene, sterol substrates and metabolites were clearly separated
and identi¢ed by GC/MS (VG 12-250 (VG BIOTECH)). The conver-
sion ratio was calculated from the areas of the two peaks and the
activity (nmol demethylated product formed/min/nmol CYP51) was
calculated from the amount of substrate added with cholesterol added
as an internal standard.
3. Results and discussion
3.1. Metabolism of lanosterol
Puri¢ed human and C. albicans CYP51 catalysed the oxi-
dative removal of the C14 methyl group from lanosterol to
the product, 4,4-dimethylcholesta-8,14,24-trien-3L-ol. Rate of
lanosterol 14K-demethylation observed under the standard as-
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say conditions as described were 0.25 nmol/min/nmol CYP51
for C. albicans and 0.18 nmol/min/nmol CYP51 for humans.
This activity was lower than those previously reported for
puri¢ed S. cerevisiae CYP51 (7.7 nmol/min/nmol CYP51
[12]), re£ecting the inherent higher activity of the yeast en-
zyme. Puri¢ed plant CYP51 showed no ability to demethylate
lanosterol. Additionally, when obtusifoliol was added in con-
junction to lanosterol to the reconstituted system for the plant
enzyme, the presence of the product formed from the demeth-
ylation of obtusifoliol, 4K-methylergosta-8,14,24(28)-trien-3L-
ol, was seen. These observations indicate that lanosterol is an
incompatible substrate for the plant enzyme whereby the
structure of this sterol molecule prevents binding to the active
site of this cytochrome. Both human and C. albicans CYP51
showed similar activity towards lanosterol, which is expected
due to the closeness of this sterol to their respective endoge-
nous substrates (Table 1).
3.2. Metabolism of 24-methylene-24,25-dihydrolanosterol and
dihydrolanosterol
24-methyleneDHL and DHL were also metabolised by the
reconstituted lanosterol demethylases of humans and C. albi-
cans to their 14K-demethylated products. 24-methyleneDHL
was shown to be a slightly better substrate for puri¢ed C.
albicans CYP51 (0.3 nmol/min/nmol) compared with other
sterol substrates used in this study which is consistent with
it being the endogenous substrate in C. albicans. Conversely,
puri¢ed human CYP51 had lower activity in its ability to
demethylate 24-methyleneDHL with an observed rate equiv-
alent to 0.22 nmol/min/nmol CYP51. Furthermore, human
CYP51 was shown to be most active in its ability to demeth-
ylate DHL in these studies (observed activity 0.5 nmol/min/
nmol CYP51) whereas C. albicans CYP51 showed lower ac-
tivity in DHL demethylation. Puri¢ed plant CYP51 had no
activity in 24-methyleneDHL and DHL demethylation in re-
constituted systems. Again, when obtusifoliol is added to
these reconstitutions, 4K-methylergosta-8,14,24(28)-trien-3L-
ol was seen, indicating an inherent inability of plant CYP51
to bind and metabolise other CYP51 substrates from di¡erent
kingdoms.
FEBS 20012 27-3-98
Fig. 1. Eukaryotic CYP51-mediated sterol 14K-demethylation. In humans, 14K-demethylation occurs on dihydrolanosterol during cholesterol bi-
osynthesis; in fungi, this reaction occurs on either lanosterol or 24-methylenne-24,25-dihydrolanosterol during ergosterol biosynthesis and in
plants obtusifoliol acts as the CYP51 substrate during phytosterol production.
Table 1
Kinetic parameters for the sterol 14K-demethylation of lanosterol,
24-methylene-24,25-dihydrolanosterol, dihydrolanosterol and obtusi-
foliol as catalysed in reconstituted systems containing puri¢ed hu-
man, C. albicans and S. bicolor CYP51 and their analogous
NADPH cytochrome P450 reductases
Substrate CYP51 orthologue
Human C. albicans S. bicolor
KMa Vmaxb KMa Vmaxb KMa Vmaxb
Lanosterol 29 0.18 15.0 0.25 ^ ^
24-methyleneDHL 32 0.22 11.0 0.3 ^ ^
Dihydrolanosterol 27 0.5 25.0 0.12 ^ ^
Obtusifoliol 32 0.44 28.5 0.26 18.0 5.5
aWM.
bActivity is expressed as nmol/min/nmol CYP51.
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3.3. Metabolism of obtusifoliol
As described above, puri¢ed plant CYP51 converted obtu-
sifoliol to the 14K-demethylated product, 4K-methylergosta-
8,14,24(28)-trien-3L-ol, as detected by GC/MS. The rate of
obtusifoliol 14K-demethylation was high (5.5 nmol/min/nmol
CYP51) with the activity una¡ected by the addition of lano-
sterol, 24-methyleneDHL and DHL. Puri¢ed human and C.
albicans CYP51 metabolised obtusifoliol to its 14K-demeth-
ylated product. However, this activity was lower than those
seen for lanosterol, 24-methyleneDHL and DHL. These re-
sults indicate that S. bicolor CYP51 is highly speci¢c for
one type of CYP51 substrate that is found in nature, obtusi-
foliol, whereas human and C. albicans CYP51 have a wide
spectrum of activity towards di¡erent CYP51 substrates.
The inability of puri¢ed S. bicolor CYP51 to metabolise
14K-demethylate lanosterol, 24-methylene-24,25-dihydrola-
nosterol and dihydrolanosterol indicates that the presence of
a structural feature common to all three sterol molecules, the
4L-methyl group (Fig. 1), prevents binding of these substrates
to the plant enzyme, as previously shown with corn micro-
somes [8]. Additionally, metabolism studies on obtusifoliol
and each other substrate present in the reconstituted system
containing puri¢ed S. bicolor CYP51 presented here reveal
only obtusifoliol to be metabolised, indicating both access of
obtusifoliol to the active site of the plant CYP51 and con-
versely, the inability of the other substrates to gain access.
Such unique substrate speci¢city of the plant enzyme is un-
usual when data for the human and fungal enzymes are com-
pared. Both these enzymes could metabolise all four sub-
strates in the present study, with con¢rmation for the ¢rst
time that their speculated endogenous substrates are indeed
favoured.
CYP51 is the only P450 form found in plants, animals and
fungi indicating both the essential role this enzyme plays in
eukaryotic cell integrity and also that CYP51s of di¡erent
organisms originated in a common ancestor [14]. It has been
suggested that the earliest role of P450 was as a defence mech-
anism in order to detoxify oxygen and its reactive intermedi-
ates, which formed during the simple processes of cellular
metabolism and photosynthesis in the primitive cell [15], but
other more primitive CYP forms may have been involved in
this. The reason for the substrate selectivity di¡erence ob-
served for the plant as opposed to human/fungal CYP51s
presumably re£ects the early divergence of the sterol biosyn-
thetic pathway in the plant kingdom.
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